Government Affairs
Refine Search
Pharmaceutical
China Food and Drug Administration’s (CFDA) Minister Bi Jingquan and Bill & Melinda Gates Foundation co-chairman Bill Gates recently officially signed the Memorandum of Understanding on Strategic Cooperation between the CFDA of the People's Republic of China and the Gates Foundation. 13 June 2016
Pharmaceutical
In Russia, pharma patents account for a large share of patent portfolios. In 2015 the government considered a draft bill on compulsory licensing of patented medicines, writes Vladimir Biriulin of law firm Gorodissky & Partners on the International Law Office site. 6 June 2016
Pharmaceutical
“A catastrophic failure,” a “failing business model” and patient anger at an “unethical situation.” 1 June 2016
Pharmaceutical
The government of Ukraine is completing preparations for the de-regulation of the national pharmaceutical market, which involves easing access of Western drug imports to the market. 1 June 2016
Pharmaceutical
The Russian government will start to limit the participation of foreign drugs in the public procurement and state tenders since the second half of the current year, according to recent statements of Arkady Dvorkovich, Russia’s Deputy Prime Minister. 1 June 2016
Biotechnology
Trade group AusBiotech’s 2016 Biotechnology Industry Position Survey of industry chief executives confirms biotechnology continues to be front and center of Australia’s post-mining boom economic transition. 31 May 2016
Biosimilars
Adoption of the European Parliament’s report on the Single Market Strategy in Plenary has been applauded by Medicines for Europe, which represents generic and biosimilar medicines producers in Europe. 26 May 2016
Pharmaceutical
The Transatlantic Trade and Investment Partnership (TTIP) could increase the annual value of European Union (EU) pharma exports by 9 billion euros ($10.03 billion) by slashing trade barriers, a study suggests. 25 May 2016
Pharmaceutical
The Association of the British Pharmaceutical Industry (ABPI) has highlighted how patients in the UK would miss out on ground-breaking clinical trials by voting to leave the European Union. 25 May 2016
Pharmaceutical
A UK government review warning of an ‘antibiotics apocalypse’ is recommending the introduction of incentives to encourage pharmaceutical companies to invest in research activity to find new drugs and treatments to tackle the ever-growing problem of antimicrobial resistance (AMR). 19 May 2016
Pharmaceutical
US Democrat presidential front runner Hillary Clinton just dipped her toe a little bit further into the waters of single-payer health care, prodded by her competitor for the Democratic presidential nomination, Senator Bernie Sanders, according to a posting on the website of the Pacific Research Institute think-tank. 17 May 2016
Pharmaceutical
A US drugmaker has joined the list of companies that have refused to supply the drugs that are used in the USA to implement capital punishment. Lethal injection has long been the most common form of execution in the USA. 14 May 2016
Pharmaceutical
Around 88% of the bodies set up to deliver health care across England are not implementing national guidelines aimed at minimising the risk of antibiotic resistance. 12 May 2016
Pharmaceutical
The Russian government has decided to postpone the introduction of a controversial scheme for the compulsory licensing of drugs imported into Russia, as proposed by some local drugmakers, reports The Pharma Letter’s local correspondent. 10 May 2016
Pharmaceutical
The Ukraine government plans to ease access to imported drugs to the domestic market, through the reduction of the time for registration of the newly-launched drugs from the current 30 to 10 days. 10 May 2016
Pharmaceutical
The UK’s leading life science companies have today (May 8., 2016) warned that leaving the European Union could add risk to the wealth and health of the nation by bringing uncertainty to the industry, adding barriers to investment in the UK and threatening access to the latest medicines, according to a press statement issued on Sunday by the Department for Business, Innovation and Skills. 8 May 2016
Pharmaceutical
The New Zealand government is increasing funding for its drugs procurement agency amid claims that medicine costs will rise under the controversial 12-nation Trans-Pacific Partnership trade agreement. 6 May 2016
Pharmaceutical
Trade group Medicines Australia has welcomed the commitment made by its country's government to a scheme to ensure patients receive timely access to innovative meds. 3 May 2016
Generics
The Russian government is considering subsidizing the production of cheap drugs, amid the fears of their disappearance from the market, according to recent statements of Arkady Dvorkovich, Russia’s Deputy Prime Minister, reports The Pharma Letter’s local correspondent. 2 May 2016
Pharmaceutical
On the heels of World Intellectual Property Day, the Office of the US Trade Representative (USTR) has released the 2016 “Special 301” Report on the global state of intellectual property rights protection and enforcement. 28 April 2016
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze